Renal Replacement Therapy in Congestive Heart Failure Requiring Left Ventricular Assist Device Augmentation
Peritoneal Dialysis International, 08/03/2012
Thomas BA et al. – There is clear evidence of the superiority of peritoneal dialysis in reducing the risk of systemic infection secondary to acute dialysis access. Given the high risk of left ventricular assist device (LVAD) infection, the authors therefore conclude that, to decrease mortality secondary to systemic infection, peritoneal dialysis should strongly be considered in patients who require renal replacement therapy before or after LVAD placement.